H-AGAVAEEVLAAIR^-OH

Ref. 3D-PP47779

Informations sur le produit

• Nom: H-AGAVAEEVLAAIR^-OH

Description

Peptide H-AGAVAEEVLAAIR^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-AGAVAEEVLAAIR^-OH include the following: Microvilli morphology can affect efflux active P-glycoprotein in confluent MDCKII-hMDR1-NKI and Caco-2 cell monolayers Z Meng, S Le Marchand, D Agnani, M Szapacs - Drug Metabolism and , 2017 - ASPEThttps://dmd.aspetjournals.org/content/45/2/145.abstract Development of a highly sensitive method using LC-MRM to quantify membrane P-glycoprotein in biological matrices and relationship to transport function T Miliotis, L Ali, JE Palm, AJ Lundqvist - Drug Metabolism and , 2011 - researchgate.nethttps://www.researchgate.net/profile/Tommy-Andersson-4/publication/51665271_Development_of_a_Highly_Sensitive_Method_Using_Liquid_Chromatography-Multiple_Reaction_Monitoring_to_Quantify_Membrane_P-Glycoprotein_in_Biological_Matrices_and_Relationship_to_Transport_Function/links/54d0ae5f0cf298d65667dfa9/Development-of-a-Highly-Sensitive-Method-Using-Liquid-Chromatography-Multiple-Reaction-Monitoring-to-Quantify-Membrane-P-Glycoprotein-in-Biological-Matrices-and-Relationship-to-Transport-Function.pdf Development of a highly sensitive method using liquid chromatography-multiple reaction monitoring to quantify membrane P-glycoprotein in biological matrices and T Miliotis, L Ali, JE Palm, AJ Lundqvist , M Ahnoff - Drug metabolism and , 2011 - ASPEThttps://dmd.aspetjournals.org/content/39/12/2440.short How to make P-glycoprotein (ABCB1, MDR1) harbor mutations and measure its expression and activity in cell cultures? P Zubiaur , M Saiz-Rodriguez, D Koller - , 2018 - Future Medicinehttps://www.futuremedicine.com/doi/abs/10.2217/pgs-2018-0101 Kvantifisering av P-glykoprotein ved bruk av LC-MS/MS MK Myhrer - 2015 - duo.uio.nohttps://www.duo.uio.no/handle/10852/44947 In vitro-in vivo extrapolation scaling factors for intestinal P-glycoprotein and breast cancer resistance protein: part I: a cross-laboratory comparison of transporter MD Harwood, B Achour , S Neuhoff , MR Russell - Drug Metabolism and , 2016 - ASPEThttps://dmd.aspetjournals.org/content/44/3/297.short A CRISPR-Cas9 generated MDCK cell line expressing human MDR1 without endogenous canine MDR1 (cABCB1): an improved tool for drug efflux studies M Karlgren, I Simoff, M Backlund, C Wegler - Journal of , 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022354917302514 Membrane transporters in human parotid gland-targeted proteomics approach J Lapczuk-Romanska, D Busch, E Gieruszczak - International Journal of , 2019 - mdpi.comhttps://www.mdpi.com/1422-0067/20/19/4825 Direct mass spectrometric identification of ABCB1 (P-glycoprotein/MDR1) from the apical membrane fraction of human placenta using fourier transform ion cyclotron HEM zu Schwabedissen , A Dreisbach - Pharmacogenetics , 2006 - journals.lww.comhttps://journals.lww.com/jpharmacogenetics/fulltext/2006/06000/direct_mass_spectrometric_identification_of_abcb1.1.aspx LC-MS/MS-based quantification of clinically relevant intestinal uptake and efflux transporter proteins C Gröer, S Bruck, Y Lai , A Paulick, A Busemann - of pharmaceutical and , 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0731708513003373 Utvikling av en kvantitativ proteomikkmetode for P-glykoprotein i mononukleacaŠre celler fra perifert blod BA Jensen - 2013 - duo.uio.nohttps://www.duo.uio.no/handle/10852/36135 Validation of human MDR1-MDCK and BCRP-MDCK cell lines to improve the prediction of brain penetration B Feng, M West, NC Patel, T Wager , X Hou - Journal of , 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022354919300905

• Marque: Biosynth